SecBot SecBot
Insider Cluster (2 insiders) ·Filed Nov 12, 2026

CDNA

CareDx, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed4d 7h ago
Insider cluster: 2 insiders, $2.4M total
Actionable Insight • Neutral

The sales are small relative to market cap and executed under 10b5-1 plans, suggesting routine portfolio diversification rather than a negative signal. Monitor for any upcoming earnings or material events that could prompt further insider activity.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$77.88
T+0 close · Nov 12, 2026 · via day close
Latest settled
−5.34%
T+1 · $73.72
Vs SPY
−3.43%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $77.88entry
  2. T+1 · 17h ago −5.34%α −3.43% · $73.72
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two CareDx insiders, including the CFO/COO and General Counsel, sold a combined $2.40M in open-market sales over a 7-day window. The CFO/COO's $2.16M sale was under a 10b5-1 plan, and the General Counsel's $241K sale was also under a 10b5-1 plan. Total sales represent 0.057% of the $4.2B market cap, which is trivial and routine.

Key Financial Metrics

Direction
selling
Total Value
$2.4M
Insiders
2

Key Facts

  • CFO/COO Keith Kennedy sold 28,300 shares at $76.55 for $2.16M under a 10b5-1 plan on 2026-11-05
  • General Counsel Jeffrey Novack sold 3,000 shares at $80.47 for $241K under a 10b5-1 plan on 2026-11-10
  • Total open-market sales: $2.40M, representing 0.057% of the $4.2B market cap
  • All sales were under 10b5-1 plans, indicating pre-planned transactions
  • No open-market purchases were reported in the cluster

Financial Impact

Total insider sales of $2.40M, or 0.057% of market cap

Risk Factors

  • Insider sales, while small, could indicate lack of conviction if followed by additional selling
  • No purchases by insiders to offset the selling signal

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
77% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CDNA-1794518999595

Track record

16 reports on CDNA

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +28.28% at T+60 after the Apr 16, 2026 report. 3 of 5 went positive at some point.

Filters
  1. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Viewing Entry $77.88 Now $73.72 −5.34% settles Feb 11
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $77.88 Now $73.72 −5.34% settles Feb 11
  3. Nov 10, 20266d ago 144 Neutral 2/10 Entry $81.17 Now $73.72 −9.18% settles Feb 9
  4. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $80.77 Now $73.72 −8.73% settles Feb 8
  5. Nov 5, 202611d ago 144 Neutral 3/10 Entry $78.56 Now $73.72 −6.16% settles Feb 4
  6. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $87.41 Now $73.72 −15.66% settles Jan 28
  7. Oct 29, 202618d ago Institutional Cluster Bearish 4/10 Entry $71.52 Now $73.72 −3.08% settles Jan 27
  8. Aug 6, 202614w ago Insider Cluster Neutral 3/10 Entry $46.69 to $86.54 Now $73.72 +57.89% ▲ +85.34% +87.47% vs SPY
  9. Aug 4, 202614w ago 144 Neutral 2/10 Entry $45.50 Now $73.72 +62.02% No price data
  10. Jul 17, 202617w ago Insider Cluster Neutral 4/10 Entry $39.73 Now $73.72 +85.55% No price data
Showing 10 of 16

US Market Status

Market Closed · Opens Wed (9h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026